首页> 外国专利> acceptable pharmaceutical compound, compound or salt thereof, pharmaceutical composition, method for inhibiting, treating and / or reducing cognitive decline and / or akzhmer's disease in a patient

acceptable pharmaceutical compound, compound or salt thereof, pharmaceutical composition, method for inhibiting, treating and / or reducing cognitive decline and / or akzhmer's disease in a patient

机译:可接受的药物化合物,化合物或其盐,药物组合物,抑制,治疗和/或减少患者认知能力下降和/或阿克麦尔病的方法

摘要

Compounds that are central nervous system drug candidates for the treatment of cognitive decline and, more particularly, Alzheimer's disease are provided. Methods of treating, inhibiting, and/or abatement of cognitive decline and/or Alzheimer's disease with a compound or pharmaceutically acceptable salt of the invention are also provided. Also provided are methods of preparing the compounds/compositions of the invention.
机译:提供了作为中枢神经系统候选药物的化合物,用于治疗认知能力下降,尤其是阿尔茨海默氏病。还提供了用本发明的化合物或药学上可接受的盐治疗,抑制和/或减轻认知下降和/或阿尔茨海默氏病的方法。还提供了制备本发明的化合物/组合物的方法。

著录项

  • 公开/公告号BR112012002246A2

    专利类型

  • 公开/公告日2019-09-24

    原文格式PDF

  • 申请/专利权人 COGNITION THERAPEUTICS INC.;

    申请/专利号BR20121102246

  • 发明设计人 GILBERT M. RISHTON;

    申请日2010-08-02

  • 分类号A61K31/045;A01N31;

  • 国家 BR

  • 入库时间 2022-08-21 12:03:50

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号